Hot Alert: Rudolph Technologies Inc. (NYSE:RTEC), Tobira Therapeutics, Inc. (NASDAQ:TBRA), Revance Therapeutics, Inc. (NASDAQ:RVNC), Ebix Inc. (NASDAQ:EBIX), Celldex Therapeutics, Inc. (NASDAQ:CLDX)

On 3 August, Rudolph Technologies Inc. (NYSE:RTEC) reported Q2 EPS of $0.23, $0.05 better than the analyst estimate of $0.18. Revenue for the quarter came in at $59.5 million versus the consensus estimate of $57.45 million. Rudolph Technologies Inc. (NYSE:RTEC) belongs to Technology sector. Its net profit margin is -1.10% and weekly performance is 16.73%. On last trading day company shares ended up $12.84. Rudolph Technologies Inc. (NYSE:RTEC) distance from 50-day simple moving average (SMA50) is 4.39%.

Tobira Therapeutics, Inc. (NASDAQ:TBRA) said that, it will report financial results for the quarter ended June 30, 2015 after market close on Tuesday, August 11, 2015. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day. Tobira Therapeutics, Inc. (NASDAQ:TBRA) shares moved up 7.24% in last trading session and ended the day at $15.25. TBRA return on assets is -130.90%. Tobira Therapeutics, Inc. (NASDAQ:TBRA) quarterly performance is 19.89%.

Revance Therapeutics, Inc. (NASDAQ:RVNC) announced that the Company will release second quarter 2015 financial results on Thursday, August 6, 2015 after the close of market. On 04 August, Revance Therapeutics, Inc. (NASDAQ:RVNC) shares decreased -0.16% and was closed at $31.77. Revance Therapeutics, Inc. (NASDAQ:RVNC) year to date (YTD) performance is 87.54%.

Ebix Inc. (NASDAQ:EBIX) announced that it plans to release its second quarter 2015 earnings results on Friday morning, August 7th and will host a conference call to review the results at 11:00 a.m. EDT the same day. Ebix Inc. (NASDAQ:EBIX) ended the last trading day at $32.56. Company weekly volatility is calculated as 3.47% and price to cash ratio as 41.42. Ebix Inc. (NASDAQ:EBIX) showed a weekly performance of 8.42%.

Celldex Therapeutics, Inc. (NASDAQ:CLDX) said that, it will release second quarter 2015 financial results on Monday, August 10, 2015 after the U.S. financial markets close. Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares remains unchanged in last trading session and ended the day at $23.30. CLDX return on assets is -48.40%. Celldex Therapeutics, Inc. (NASDAQ:CLDX) quarterly performance is -4.15%.

Leave a Reply

Your email address will not be published. Required fields are marked *